Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …

Background Allogeneic hematopoietic stem cell transplantation (HSCT) can expose patients
to a transient but marked immunosuppression, during which viral infections are an important …

Purpose Improvement of cure rates for patients treated with allogeneic hematopoietic stem-
cell transplantation (HSCT) will require efforts to decrease treatment-related mortality from …

Single-center studies have reported an association between early (before day 100)
cytomegalovirus (CMV) reactivation and decreased incidence of relapse for acute myeloid …

T-cell responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
been described in recovered patients, and may be important for immunity following infection …

Abstract The Practice Guidelines Committee of the American Society for Transplantation and
Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to …

It remains difficult to treat the multiplicity of distinct viral infections that afflict
immunocompromised patients. Adoptive transfer of virus-specific T cells (VSTs) can be safe …

Despite recent advances in the field of allogeneic hematopoietic stem cell transplantation
(HSCT), viral infections are still a major complication during the period of immune …

Cytomegalovirus (CMV) infection is a common, potentially life-threatening complication
following allogeneic hematopoietic stem cell transplantation (allo-HSCT). We assessed …

Human cytomegalovirus (HCMV) reactivation is a major infectious cause of morbidity and
mortality after allogeneic hematopoietic stem cell transplantation (HSCT). HCMV is a …